Nanocarriers for vascular delivery of antioxidants

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Christofidou-Solomidou M, Muzykantov VR. Antioxidant strategies in respiratory medicine. Treat. Respir. Med.5(1),47–78 (2006).
  Medline CASGoogle Scholar
• 2  Muzykantov VR. Targeting of superoxide dismutase and catalase to vascular endothelium. J. Control. Release71(1),1–21 (2001).
  Medline CASGoogle Scholar
• 3  Yi X, Zimmerman MC, Yang R, Tong J, Vinogradov S, Kabanov AV. Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons. Free Radic. Biol. Med.49(4),548–558 (2010).
  Medline CASGoogle Scholar
• 4  Muzykantov VR. Delivery of antioxidant enzyme proteins to the lung. Antioxid. Redox Signal.3(1),39–62 (2001).
  Medline CASGoogle Scholar
• 5  Suarna C, Wu BJ, Choy K et al. Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency. Free Radic. Biol. Med.41(5),722–730 (2006).
  Medline CASGoogle Scholar
• 6  Siekmeier R, Steffen C, Marz W. Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations. J. Cardiovasc. Pharmacol. Ther.12(4),265–282 (2007).
  Medline CASGoogle Scholar
• 7  Thomson MJ, Puntmann V, Kaski JC. Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment? Cardiovasc. Drugs Ther.21(3),195–210 (2007).
  Medline CASGoogle Scholar
• 8  Dziubla TD, Muro S, Muzykantov VR, Koval M. Nanoscale antioxidant therapeutics. In: Oxidative Stress, Disease and Cancer. Singh KK (Ed.). Imperial College Press, London, UK (2006).
  Google Scholar
• 9  Delles C, Miller WH, Dominiczak AF. Targeting reactive oxygen species in hypertension. Antioxid. Redox Signal.10(6),1061–1077 (2008).
  Medline CASGoogle Scholar
• 10  Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J. Control. Release113(3),189–207 (2006).
  Medline CASGoogle Scholar
• 11  Muzykantov VR, Atochina EN, Ischiropoulos H, Danilov SM, Fisher AB. Immunotargeting of antioxidant enzyme to the pulmonary endothelium. Proc. Natl Acad. Sci. USA93(11),5213–5218 (1996).
  Medline CASGoogle Scholar
• 12  Muzykantov VR, Christofidou-Solomidou M, Balyasnikova I et al. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc. Natl Acad. Sci. USA96(5),2379–2384 (1999).
  Medline CASGoogle Scholar
• 13  Nowak K, Weih S, Metzger R et al. Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo. Am. J. Physiol. Lung Cell Mol. Physiol.293(1),L162–L169 (2007).
  Medline CASGoogle Scholar
• 14  Shuvaev VV, Tliba S, Nakada M, Albelda SM, Muzykantov VR. Platelet-endothelial cell adhesion molecule-1-directed endothelial targeting of superoxide dismutase alleviates oxidative stress caused by either extracellular or intracellular superoxide. J. Pharmacol. Exp. Ther.323(2),450–457 (2007).
  Medline CASGoogle Scholar
• 15  Shuvaev VV, Christofidou-Solomidou M, Bhora F et al. Targeted detoxification of selected reactive oxygen species in the vascular endothelium. J. Pharmacol. Exp. Ther.331(2),404–411 (2009).
  Medline CASGoogle Scholar
• 16  Shuvaev VV, Han J, Yu KJ et al. PECAM-targeted delivery of SOD inhibits endothelial inflammatory response. FASEB J.25(1),348–357 (2010).
  MedlineGoogle Scholar
• 17  Kozower BD, Christofidou-Solomidou M, Sweitzer TD et al. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat. Biotechnol.21(4),392–398 (2003).
  Medline CASGoogle Scholar
• 18  Christofidou-Solomidou M, Scherpereel A, Wiewrodt R et al. PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. Am. J. Physiol. Lung Cell Mol. Physiol.285(2),L283–292 (2003).
  Medline CASGoogle Scholar
• 19  Muro S, Wiewrodt R, Thomas A et al. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J. Cell Sci.116(Pt 8),1599–1609 (2003).
  Medline CASGoogle Scholar
• 20  Wiewrodt R, Thomas AP, Cipelletti L et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood99(3),912–922 (2002).
  Medline CASGoogle Scholar
• 21  Muro S, Cui X, Gajewski C, Murciano JC, Muzykantov VR, Koval M. Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am. J. Physiol. Cell Physiol.285(5),C1339–C1347 (2003).
  Medline CASGoogle Scholar
• 22  Muro S, Gajewski C, Koval M, Muzykantov VR. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood105(2),650–658 (2005).
  Medline CASGoogle Scholar
• 23  Stenesh J. Biochemistry. Plenum, NY, USA (1998).
  Google Scholar
• 24  Papi A, Chicca M, Pandit A, Caramori G, Geoffrey JL, Steven DS. Oxidants and antioxidants/Antioxidants, Nonenzymatic. In: Encyclopedia of Respiratory Medicine. Academic Press, Oxford, UK, 266–271 (2006).
  Google Scholar
• 25  Quideau S, Deffieux D, Douat-Casassus C, Pouysegu L. Plant polyphenols: chemical properties, biological activities, and synthesis. Angew Chem. Int. Ed. Engl.50(3),586–621 (2011).
  Medline CASGoogle Scholar
• 26  Sandur SK, Ichikawa H, Pandey MK et al. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic. Biol. Med.43(4),568–580 (2007).
  Medline CASGoogle Scholar
• 27  Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver cancer: a review. Curr. Pharm. Biotechnol. (2011) (Epub ahead of print).
  Google Scholar
• 28  Pezzuto JM. The phenomenon of resveratrol: redefining the virtues of promiscuity. Ann. NY Acad. Sci.1215(1),123–130 (2011).
  Medline CASGoogle Scholar
• 29  Freeman BA, Young SL, Crapo JD. Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury. J. Biol. Chem.258(20),12534–12542 (1983).
  Medline CASGoogle Scholar
• 30  Chorny M, Hood E, Levy RJ, Muzykantov VR. Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles. J. Control. Release146(1),144–151 (2010).▪ Nonsolvent, nonshear preparation of magnetically active nanocarriers efficiently load active catalase or SOD, provide proteins with protection from proteolysis and protect cells from oxidative damage from hydrogen peroxide in vitro.
  Medline CASGoogle Scholar
• 31  Batrakova EV, Li S, Reynolds AD et al. A macrophage-nanozyme delivery system for Parkinson’s disease. Bioconjug. Chem.18(5),1498–1506 (2007).
  Medline CASGoogle Scholar
• 32  Vertegel AA, Reukov V, Maximov V. Enzyme-nanoparticle conjugates for biomedical applications. Methods Mol. Biol.679,165–182 (2011).
  Medline CASGoogle Scholar
• 33  Nagami H, Yoshimoto N, Umakoshi H, Shimanouchi T, Kuboi R. Liposome-assisted activity of superoxide dismutase under oxidative stress. J. Biosci. Bioeng.99(4),423–428 (2005).
  Medline CASGoogle Scholar
• 34  Stone WL, Smith M. Therapeutic uses of antioxidant liposomes. Mol. Biotechnol.27(3),217–230 (2004).
  Medline CASGoogle Scholar
• 35  Gonnet M, Lethuaut L, Boury F. New trends in encapsulation of liposoluble vitamins. J. Control. Release146(3),276–290 (2010).
  Medline CASGoogle Scholar
• 36  Alipour M, Omri A, Smith MG, Suntres ZE. Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries. J. Endo. Res.13(5),297–304 (2007).
  Medline CASGoogle Scholar
• 37  Mitsopoulos P, Omri A, Alipour M, Vermeulen N, Smith MG, Suntres ZE. Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents. Int. J. Pharma.363(1–2),106–111 (2008).▪▪ Liposomal delivery of antioxidants provided protection against LPS in multiple lung injury measures.
  Medline CASGoogle Scholar
• 38  Fan J, Shek PN, Suntres ZE, Li YH, Oreopoulos GD, Rotstein OD. Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery128(2),332–338 (2000).
  Medline CASGoogle Scholar
• 39  Mukhopadhyay S, Mukherjee S, Stone WL, Smith M, Das SK. Role of MAPK/AP-1 signaling pathway in the protection of CEES-induced lung injury by antioxidant liposome. Toxicology261(3),143–151 (2009).
  Medline CASGoogle Scholar
• 40  Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC. Advanced drug-delivery systems of curcumin for cancer chemoprevention. Cancer Prev. Res. (Phila).4(8),1158–1171 (2011).
  Medline CASGoogle Scholar
• 41  Thangapazham RL, Puri A, Tele S, Blumenthal R, Maheshwari RK. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int. J. Oncol.32(5),1119–1123 (2008).
  Medline CASGoogle Scholar
• 42  Hung CF, Chen JK, Liao MH, Lo HM, Fang JY. Development and evaluation of emulsion-liposome blends for resveratrol delivery. J. Nanosci. Nanotechnol.6(9–10),2950–2958 (2006).
  Medline CASGoogle Scholar
• 43  Narayanan NK, Nargi D, Randolph C, Narayanan BA. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer125(1),1–8 (2009).
  Medline CASGoogle Scholar
• 44  Williams SR, Lepene BS, Thatcher CD, Long TE. Synthesis and characterization of poly(ethylene glycol)-glutathione conjugate self-assembled nanoparticles for antioxidant delivery. Biomacromolecules10(1),155–161 (2009).
  Medline CASGoogle Scholar
• 45  Tanswell AK, Freeman BA. Liposome-entrapped antioxidant enzymes prevent lethal O2 toxicity in the newborn rat. J. Appl. Physiol.63(1),347–352 (1987).
  Medline CASGoogle Scholar
• 46  Briscoe P, Caniggia I, Graves A et al. Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. Am. J. Physiol.268(3 Pt 1),L374–380 (1995).
  Medline CASGoogle Scholar
• 47  Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation95(3),588–593 (1997).
  Medline CASGoogle Scholar
• 48  Corvo LM, Jorge JCS, van’t Hof R, Cruz MEM, Crommelin DJA, Storm G. Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis. Biochim. Biophys. Acta1564(1),227–236 (2002).
  MedlineGoogle Scholar
• 49  Gaspar MM, Martins MB, Corvo ML, Cruz ME. Design and characterization of enzymosomes with surface-exposed superoxide dismutase. Biochim. Biophys. Acta1609(2),211–217 (2003).
  Medline CASGoogle Scholar
• 50  Gaspar MM, Boerman OC, Laverman P, Corvo ML, Storm G, Cruz ME. Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis. J. Control. Release117(2),186–195 (2007).
  Medline CASGoogle Scholar
• 51  Brynskikh AM, Zhao Y, Mosley RL et al. Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson’s disease. Nanomedicine5(3),379–396 (2010).
  CASGoogle Scholar
• 52  Rosenbaugh EG, Roat JW, Gao L et al. The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase. Biomaterials31(19),5218–5226 (2010).
  Medline CASGoogle Scholar
• 53  Batrakova EV, Li S, Miller DW, Kabanov AV. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm. Res.16(9),1366–1372 (1999).
  Medline CASGoogle Scholar
• 54  Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV, Elmquist WF. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J. Pharmacol. Exp. Ther.296(2),551–557 (2001).
  Medline CASGoogle Scholar
• 55  Batrakova EV, Zhang Y, Li Y et al. Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier. Pharm. Res.21(11),1993–2000 (2004).
  Medline CASGoogle Scholar
• 56  Chorny M, Fishbein I, Alferiev I, Levy RJ. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. Mol. Pharm.6(5),1380–1387 (2009).
  Medline CASGoogle Scholar
• 57  Shuvaev VV, Tliba S, Pick J et al. Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates. J. Control. Release149(3),236–241 (2011).
  Medline CASGoogle Scholar
• 58  Villano D, Fernandez-Pachon MS, Moya ML, Troncoso AM, Garcia-Parrilla MC. Radical scavenging ability of polyphenolic compounds towards DPPH free radical. Talanta71(1),230–235 (2007).
  Medline CASGoogle Scholar
• 59  Rock CL, Jacob RA, Bowen PE. Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids. J. Am. Diet Assoc.96(7),693–702; quiz 703–694 (1996).
  Medline CASGoogle Scholar
• 60  de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans.35(Pt 5),1156–1160 (2007).
  MedlineGoogle Scholar
• 61  Wattamwar PP, Hardas SS, Butterfield DA, Anderson KW, Dziubla TD. Tuning of the pro-oxidant and antioxidant activity of trolox through the controlled release from biodegradable poly(trolox ester) polymers. Acta Biomaterialia (2011) (In Press).
  Google Scholar
• 62  Kumar V, Prud’Homme RK. Thermodynamic limits on drug loading in nanoparticle cores. J. Pharm. Sci.97(11),4904–4914 (2008).
  Medline CASGoogle Scholar
• 63  De Villiers MM, Aramwit P, Kwon GS. Nanotechnology in Drug Delivery. Springer, AAPS Press, NY and VA, USA (2009).
  Google Scholar
• 64  Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science263(5153),1600–1603 (1994).
  Medline CASGoogle Scholar
• 65  Leonarduzzi G, Testa G, Sottero B, Gamba P, Poli G. Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Curr. Med. Chem.17(1),74–95.
  MedlineGoogle Scholar
• 66  Kumar V, Hong SY, Maciag AE et al. Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and double JS-K, through incorporation into PEG-protected nanoparticles. Mol. Pharm.7(1),291–298 (2010).
  Medline CASGoogle Scholar
• 67  Wattamwar PP, Mo YQ, Wan R, Palli R, Zhang QW, Dziubla TD. Antioxidant activity of degradable polymer poly(trolox ester) to suppress oxidative stress injury in the cells. Adv. Func. Mater.20(1),147–154 (2010).
  CASGoogle Scholar
• 68  Fleming C, Maldjian A, Da Costa D et al. A carbohydrate-antioxidant hybrid polymer reduces oxidative damage in spermatozoa and enhances fertility. Nat. Chem. Biol.1(5),270–274 (2005).
  Medline CASGoogle Scholar
• 69  Spizzirri UG, Iemma F, Puoci F et al. Synthesis of antioxidant polymers by grafting of gallic acid and catechin on gelatin. Biomacromolecules10(7),1923–1930 (2009).
  Medline CASGoogle Scholar
• 70  Wang Y, Singh A, Xu P, Pindrus MA, Blasioli DJ, Kaplan DL. Expansion and osteogenic differentiation of bone marrow-derived mesenchymal stem cells on a vitamin C functionalized polymer. Biomaterials27(17),3265–3273 (2006).
  Medline CASGoogle Scholar
• 71  Dziubla TD, Karim A, Muzykantov VR. Polymer nanocarriers protecting active enzyme cargo against proteolysis. J. Control. Release102(2),427–439 (2005).
  Medline CASGoogle Scholar
• 72  Giovagnoli S, Luca G, Casaburi I et al. Long-term delivery of superoxide dismutase and catalase entrapped in poly(lactide-co-glycolide) microspheres: In vitro effects on isolated neonatal porcine pancreatic cell clusters. J. Control. Release107(1),65–77 (2005).
  Medline CASGoogle Scholar
• 73  Seshadri G, Sy JC, Brown M et al. The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury. Biomaterials31(6),1372–1379 (2010).
  Medline CASGoogle Scholar
• 74  Fiore VF, Lofton MC, Roser-Page S et al. Polyketal microparticles for therapeutic delivery to the lung. Biomaterials31(5),810–817 (2010).
  Medline CASGoogle Scholar
• 75  Dziubla TD, Shuvaev VV, Hong NK et al. Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. Biomaterials29(2),215–227 (2008).▪▪ Degradable polymer nanocarriers modified to accommodate endothelial targeting antibodies successfully load active catalase, bind to endothelial cells and impart antioxidant protection.
  Medline CASGoogle Scholar
• 76  Reddy MK, Wu L, Kou W, Ghorpade A, Labhasetwar V. Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Appl. Biochem. Biotechnol.151(2–3),565–577 (2008).
  Medline CASGoogle Scholar
• 77  Reddy MK, Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J.23(5),1384–1395 (2009).
  Medline CASGoogle Scholar
• 78  Muro S, Dziubla T, Qiu W et al. Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J. Pharmacol. Exp. Ther.317(3),1161–1169 (2006).
  Medline CASGoogle Scholar
• 79  Yan M, Du JJ, Gu Z et al. A novel intracellular protein delivery platform based on single-protein nanocapsules. Nat. Nanotechnol.5(1),48–53 (2010).▪ Novel biodegradable protein delivery nanocapsules.
  Medline CASGoogle Scholar
• 80  Kim D, Kim E, Kim J et al. Direct synthesis of polymer nanocapsules with a noncovalently tailorable surface. Angew. Chem. Int. Ed.46(19),3471–3474 (2007).
  Medline CASGoogle Scholar
• 81  Kim E, Kim D, Jung H et al. Facile, Template-Free Synthesis of Stimuli-Responsive Polymer Nanocapsules for Targeted Drug Delivery. Angew. Chem. Int. Ed.49(26),4405–4408 (2010).
  Medline CASGoogle Scholar
• 82  Photos PJ, Bacakova L, Discher B, Bates FS, Discher DE. Polymer vesicles in vivo: correlations with PEG molecular weight. J. Control. Release90(3),323–334 (2003).
  Medline CASGoogle Scholar
• 83  Saad M, Garbuzenko OB, Ber E et al. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? J. Control. Release130(2),107–114 (2008).
  Medline CASGoogle Scholar
• 84  Dziubla TD, Karim A, Muzykantov VR. Polymer nanocarriers protecting active enzyme cargo against proteolysis. J. Control. Release102(2),427–439 (2005).
  Medline CASGoogle Scholar
• 85  Ahmed F, Discher DE. Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. J. Control. Release96(1),37–53 (2004).
  Medline CASGoogle Scholar
• 86  Zarif L. Elongated supramolecular assemblies in drug delivery. J. Control. Release81(1–2),7–23 (2002).
  Medline CASGoogle Scholar
• 87  Bianco A, Kostarelos K, Prato M. Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin. Drug Deliv.5(3),331–342 (2008).
  Medline CASGoogle Scholar
• 88  Champion JA, Mitragotri S. Role of target geometry in phagocytosis. Proc. Natl Acad. Sci. USA103(13),4930–4934 (2006).▪▪ Demonstrates that the effect of high aspect ratio and shape on inhibition of phagocytosis of drug-delivery particles is possible by minimizing the size-normalized curvature of particles.
  Medline CASGoogle Scholar
• 89  Muro S, Garnacho C, Champion JA et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther.16(8),1450–1458 (2008).
  Medline CASGoogle Scholar
• 90  Xu S, Nie Z, Seo M et al. Generation of monodisperse particles by using microfluidics: control over size, shape, and composition. Angew. Chem. Int. Ed. Engl.44(5),724–728 (2005).
  Medline CASGoogle Scholar
• 91  Dendukuri D, Pregibon DC, Collins J, Hatton TA, Doyle PS. Continuous-flow lithography for high-throughput microparticle synthesis. Nat. Mater.5(5),365–369 (2006).
  Medline CASGoogle Scholar
• 92  Gratton SE, Pohlhaus PD, Lee J, Guo J, Cho MJ, Desimone JM. Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. J. Control. Release121(1–2),10–18 (2007).▪ Investigates cellular internalization pathways of varied size, shape and surface charge of nanofabricated particles.
  Medline CASGoogle Scholar
• 93  Rolland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, DeSimone JM. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc.127(28),10096–10100 (2005).
  Medline CASGoogle Scholar
• 94  Gratton SE, Napier ME, Ropp PA, Tian S, Desimone JM. Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles. Pharm. Res.25(12),2845–2852 (2008).
  Medline CASGoogle Scholar
• 95  Lee JC, Bermudez H, Discher BM et al. Preparation, stability, and in vitro performance of vesicles made with diblock copolymers. Biotechnol. Bioeng.73(2),135–145 (2001).
  Medline CASGoogle Scholar
• 96  Discher DE, Eisenberg A. Polymer vesicles. Science297(5583),967–973 (2002).
  Medline CASGoogle Scholar
• 97  Lee JC, Wong DT, Discher DE. Direct measures of large, anisotropic strains in deformation of the erythrocyte cytoskeleton. Biophys. J.77(2),853–864 (1999).
  Medline CASGoogle Scholar
• 98  Dalhaimer P, Bates FS, Discher DE. Single molecule visualization of stable, stiffness-tunable, flow-conforming worm micelles. Macromolecules36(18),6873–6877 (2003).
  CASGoogle Scholar
• 99  Simone EA, Dziubla TD, Colon-Gonzalez F, Discher DE, Muzykantov VR. Effect of polymer amphiphilicity on loading of a therapeutic enzyme into protective filamentous and spherical polymer nanocarriers. Biomacromolecules8(12),3914–3921 (2007).
  Medline CASGoogle Scholar
• 100  Simone EA, Dziubla TD, Discher DE, Muzykantov VR. Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase. Biomacromolecules10(6),1324–1330 (2009).
  Medline CASGoogle Scholar
• 101  Petros RA, Ropp PA, DeSimone JM. Reductively labile PRINT particles for the delivery of doxorubicin to HeLa cells. J. Am. Chem. Soc.130(15),5008–5009 (2008).
  Medline CASGoogle Scholar
• 102  Kelly JY, DeSimone JM. Shape-specific, monodisperse nano-molding of protein particles. J. Am. Chem. Soc.130(16),5438–5439 (2008).
  Medline CASGoogle Scholar
• 103  Castillo J, Curley J, Hotz J et al. Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology85(5),1157–1166 (1996).
  Medline CASGoogle Scholar
• 104  Hickey T, Kreutzer D, Burgess DJ, Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials23(7),1649–1656 (2002).
  Medline CASGoogle Scholar
• 105  Simone EA, Dziubla TD, Arguiri E et al. Loading PEG-catalase into filamentous and spherical polymer nanocarriers. Pharm. Res.26(1),250–260 (2009).
  Medline CASGoogle Scholar
• 106  Kumar N, Ravikumar MN, Domb AJ. Biodegradable block copolymers. Adv. Drug Deliv. Rev.53(1),23–44 (2001).
  Medline CASGoogle Scholar
• 107  Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev.28(1),5–24 (1997).
  Medline CASGoogle Scholar
• 108  Siepmann J, Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv. Drug Deliv. Rev.48(2–3),229–247 (2001).
  Medline CASGoogle Scholar
• 109  Hanes J, Chiba M, Langer R. Synthesis and characterization of degradable anhydride-co-imide terpolymers containing trimellitylimido-L-tyrosine: novel polymers for drug delivery. Macromolecules29(16),5279–5287 (1996).
  CASGoogle Scholar
• 110  Leong KW, Brott BC, Langer R. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J. Biomed. Mater. Res.19(8),941–955 (1985).
  Medline CASGoogle Scholar
• 111  Tabata Y, Gutta S, Langer R. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm. Res.10(4),487–496 (1993).
  Medline CASGoogle Scholar
• 112  Carino GP, Jacob JS, Mathiowitz E. Nanosphere based oral insulin delivery. J. Control. Release65(1–2),261–269 (2000).
  Medline CASGoogle Scholar
• 113  Fu J, Wu C. Laser light scattering of the degradation of poly(sebacic anhydride) nanoparticles. J. Polymer Sci. B Polymer Phys.39(6),703–708 (2001).
  CASGoogle Scholar
• 114  Pfeifer BA, Burdick JA, Langer R. Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres. Biomaterials26(2),117–124 (2005).
  Medline CASGoogle Scholar
• 115  Li S, Garreau H, Vert M. Structure-property relationships in the case of the degradation of solid aliphatic poly-(α-hydroxy acids) in aqueous media part 3 influence of the morphology of poly(L-lactic acid). J. Mat. Sci.1(4),198–206 (1990).
  CASGoogle Scholar
• 116  Li S, Garreau H, Vert M: Structure-property relationships in the case of the degradation of solid aliphatic poly-(α-hydroxy acids) in aqueous media. Part 1 Poly(DL-lactic acid). J. Mat. Sci.1(3),123 (1990).
  CASGoogle Scholar
• 117  Vert M, Li SM, Garreau H. Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J. Biomater. Sci. Polym. Ed.6(7),639–649 (1994).
  Medline CASGoogle Scholar
• 118  Geng Y, Discher DE. Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. J. Am. Chem. Soc.127(37),12780–12781 (2005).
  Medline CASGoogle Scholar
• 119  Shih C. A graphical method for the determination of the mode of hydrolysis of biodegradable polymers. Pharm. Res.12(12),2036–2060 (1995).
  Medline CASGoogle Scholar
• 120  Ahmed F, Pakunlu RI, Srinivas G et al. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol. Pharm.3(3),340–350 (2006).
  Medline CASGoogle Scholar
• 121  Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials17(2),103–114 (1996).
  Medline CASGoogle Scholar
• 122  Li S, Molina I, Martinez MB, Vert M. Hydrolytic and enzymatic degradations of physically crosslinked hydrogels prepared from PLA/PEO/PLA triblock copolymers. J. Mater. Sci. Mater. Med.13(1),81–86 (2002).
  Medline CASGoogle Scholar
• 123  MacDonald RT, McCarthy SP, Gross RA. Enzymatic degradability of poly(lactide): effects of chain stereochemistry and material crystallinity. Macromolecules29(23),7356–7361 (1996).
  CASGoogle Scholar
• 124  Tokiwa Y, Jarerat A. Biodegradation of poly(L-lactide). Biotechnol. Lett.26(10),771–777 (2004).
  Medline CASGoogle Scholar
• 125  Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett.268(1),235–237 (1990).
  Medline CASGoogle Scholar
• 126  Bermudez H, Brannan AK, Hammer DA, Bates FS, Discher DE. Molecular weight dependence of polymersome membrane structure, elasticity, and stability. Macromolecules35(21),8203–8208 (2002).
  CASGoogle Scholar
• 127  Geng Y, Dalhaimer P, Cai S et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nano.2(4),249–255 (2007).
  Medline CASGoogle Scholar
• 128  Bedu-Addo FK, Tang P, Xu Y, Huang L. Interaction of polyethyleneglycol-phospholipid conjugates with cholesterol-phosphatidylcholine mixtures: sterically stabilized liposome formulations. Pharm. Res.13(5),718–724 (1996).
  Medline CASGoogle Scholar
• 129  Koval M, Preiter K, Adles C, Stahl PD, Steinberg TH. Size of IgG-opsonized particles determines macrophage response during internalization. Exp. Cell Res.242(1),265–273 (1998).
  Medline CASGoogle Scholar
• 130  Brewer JM, Tetley L, Richmond J, Liew FY, Alexander J. Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen. J. Immunol.161(8),4000–4007 (1998).
  Medline CASGoogle Scholar
• 131  Romero EL, Morilla MJ, Regts J, Koning GA, Scherphof GL. On the mechanism of hepatic transendothelial passage of large liposomes. FEBS Lett.448(1),193–196 (1999).
  Medline CASGoogle Scholar
• 132  Champion JA, Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm. Res.26(1),244–249 (2008).
  MedlineGoogle Scholar
• 133  Izumisawa T, Hattori Y, Date M, Toma K, Maitani Y. Cell line-dependent internalization pathways determine DNA transfection efficiency of decaarginine-PEG-lipid. Int. J. Pharm.404(1–2),264–270 (2010).
  MedlineGoogle Scholar
• 134  Shi F, Wasungu L, Nomden A et al. Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. Biochem. J.366(Pt 1),333–341 (2002).
  Medline CASGoogle Scholar
• 135  Aoki H, Fujita M, Sun CQ, Fuji K, Miyajima K. High-efficiency entrapment of superoxide dismutase into cationic liposomes containing synthetic aminoglycolipid. Chem. Pharm. Bull.45(8),1327–1331 (1997).
  Medline CASGoogle Scholar
• 136  Atochina EN, Balyasnikova IV, Danilov SM, Granger DN, Fisher AB, Muzykantov VR. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. Am. J. Physiol.275(4 Pt 1),L806–817 (1998).
  Medline CASGoogle Scholar
• 137  Deneke SM. Thiol-based antioxidants. Curr. Top. Cell Regul.36,151–180 (2000).
  Medline CASGoogle Scholar
• 138  Pedersen PJ, Adolph SK, Subramanian AK et al. Liposomal formulation of retinoids designed for enzyme triggered release. J. Med. Chem.53(9),3782–3792 (2010).
  Medline CASGoogle Scholar
• 139  Trapasso E, Cosco D, Celia C, Fresta M, Paolino D. Retinoids: new use by innovative drug-delivery systems. Expert Opin. Drug Deliv.6(5),465–483 (2009).
  Medline CASGoogle Scholar
• 140  Wegmann Jr, Krucker M, Bachmann S et al. Characterization of lycopene nanoparticles combining solid-state and suspended-state NMR spectroscopy. J. Agricult. Food Chem.50(26),7510–7514 (2002).
  Medline CASGoogle Scholar
• 141  Palozza P, Muzzalupo R, Trombino S, Valdannini A, Picci N. Solubilization and stabilization of [beta]-carotene in niosomes: delivery to cultured cells. Chem. Phys. Lipids139(1),32–42 (2006).
  Medline CASGoogle Scholar
• 142  Robb EL, Page MM, Wiens BE, Stuart JA. Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem. Biophys. Res. Comm.367(2),406–412 (2008).
  Medline CASGoogle Scholar
• 143  Mignet N, Seguin J, Romano MR et al. Development of a liposomal formulation of the natural flavonoid fisetin. Int. J. Pharm. (2011) (In Press).
  MedlineGoogle Scholar
• 144  Yuan Z-p, Chen L-j, Fan L-y et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin. Cancer Res.12(10),3193–3199 (2006).
  Medline CASGoogle Scholar
• 145  Gao L, Liu G, Wang X, Liu F, Xu Y, Ma J. Preparation of a chemically stable quercetin formulation using nanosuspension technology. Int. J. Pharm.404(1–2),231–237 (2010).
  MedlineGoogle Scholar
• 146  Nilsson L, Löf D, BergenstÃ¥hl Br. Phenolic acid nanoparticle formation in iron-containing aqueous solutions. J. Agricult. Food Chem.56(23),11453–11457 (2008).
  Medline CASGoogle Scholar
• 147  Coimbra M, Isacchi B, van Bloois L et al. Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. Int. J. Pharm. (2011) (In Press).
  MedlineGoogle Scholar
• 148  Teskac K, Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm.390(1),61–69 (2009).
  MedlineGoogle Scholar
• 149  Frozza RL, Bernardi A, Paese K et al. Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J. Biomed. Nanotechnol.6(6),694–703 (2011).
  Google Scholar
• 150  Lee W-C, Tsai T-H. Preparation and characterization of liposomal coenzyme Q10 for in vivo topical application. Int. J. Pharm.395(1–2),78–83 (2010).
  Medline CASGoogle Scholar
• 151  Beg S, Javed S, Kohli K. Bioavailability enhancement of coenzyme Q10: an extensive review of patents. Recent Pat. Drug Deliv. Formul.4(3),245–255 (2010).
  Medline CASGoogle Scholar
• 152  Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev.61(6),428–437 (2009).
  Medline CASGoogle Scholar
• 153  Carnemolla R, Shuvaev VV, Muzykantov VR. Targeting antioxidant and antithrombotic biotherapeutics to endothelium. Semin. Thromb. Hemost.36(3),332–342 (2010).
  Medline CASGoogle Scholar
• 154  Harush-Frenkel O, Altschuler Y, Benita S. Nanoparticle-cell interactions: drug delivery implications. Crit. Rev. Ther. Drug Carrier Syst.25(6),485–544 (2008).
  Medline CASGoogle Scholar
• 155  Sun X, Zhang N. Cationic polymer optimization for efficient gene delivery. Mini Rev. Med. Chem.10(2),108–125 (2010).
  Medline CASGoogle Scholar
• 156  Simone EA, Dziubla TD, Muzykantov VR. Polymeric carriers: role of geometry in drug delivery. Expert Opin. Drug Deliv.5(12),1283–1300 (2008).▪ Recent review on the role that the size, shape and surface modifications play on polymer carriers in vitro and in vivo localization and drug delivery.
  Medline CASGoogle Scholar
• 157  Tao L, Hu W, Liu Y, Huang G, Sumer BD, Gao J. Shape-specific polymeric nanomedicine: emerging opportunities and challenges. Exp. Biol. Med.236(1),20–29 (2011).
  Medline CASGoogle Scholar
• 158  Caldorera-Moore M, Guimard N, Shi L, Roy K. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin. Drug Deliv.7(4),479–495 (2010).
  Medline CASGoogle Scholar
• 159  Hillaireau H, Couvreur P. Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol. Life Sci.66(17),2873–2896 (2009).
  Medline CASGoogle Scholar
• 160  Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev.48(2–3),139–157 (2001).
  Medline CASGoogle Scholar
• 161  Gao W, Chan JM, Farokhzad OC. pH-Responsive nanoparticles for drug delivery. Mol. Pharm.7(6),1913–1920 (2010).
  Medline CASGoogle Scholar
• 162  Yoo JW, Chambers E, Mitragotri S. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr. Pharm. Des.16(21),2298–2307 (2010).
  Medline CASGoogle Scholar